You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study

Citation Tools

Article menu

Download PDFPDF

XML
Emerging Technologies, Pharmacology and Therapeutics
Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Inagaki N, Chou HS, Tsukiyama S, et al
Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study
BMJ Open Diabetes Research and Care 2017;5:e000424. doi: 10.1136/bmjdrc-2017-000424